Nuveen Asset Management LLC Has $22.73 Million Stock Holdings in Henry Schein, Inc. (NASDAQ:HSIC)

Nuveen Asset Management LLC reduced its position in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 1.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 328,469 shares of the company's stock after selling 3,805 shares during the period. Nuveen Asset Management LLC owned approximately 0.26% of Henry Schein worth $22,730,000 at the end of the most recent quarter.

A number of other hedge funds have also recently bought and sold shares of HSIC. Venturi Wealth Management LLC grew its holdings in Henry Schein by 3,347.1% during the fourth quarter. Venturi Wealth Management LLC now owns 586 shares of the company's stock worth $41,000 after acquiring an additional 569 shares during the period. Quent Capital LLC boosted its position in Henry Schein by 91.2% during the 4th quarter. Quent Capital LLC now owns 677 shares of the company's stock worth $47,000 after acquiring an additional 323 shares during the period. Smartleaf Asset Management LLC boosted its position in Henry Schein by 23.2% during the 4th quarter. Smartleaf Asset Management LLC now owns 759 shares of the company's stock worth $52,000 after acquiring an additional 143 shares during the period. Allworth Financial LP lifted its holdings in shares of Henry Schein by 180.7% during the 4th quarter. Allworth Financial LP now owns 946 shares of the company's stock valued at $71,000 after buying an additional 609 shares during the last quarter. Finally, Canada Post Corp Registered Pension Plan acquired a new stake in shares of Henry Schein during the 4th quarter valued at about $95,000. 96.62% of the stock is owned by institutional investors and hedge funds.

Henry Schein Stock Performance

Shares of HSIC traded down $0.13 on Thursday, reaching $73.28. 184,971 shares of the stock traded hands, compared to its average volume of 1,658,438. The firm has a market cap of $8.92 billion, a price-to-earnings ratio of 30.15, a P/E/G ratio of 2.13 and a beta of 0.87. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. Henry Schein, Inc. has a 12 month low of $60.56 and a 12 month high of $82.49. The stock's 50-day moving average price is $67.62 and its 200-day moving average price is $71.59.

Henry Schein (NASDAQ:HSIC - Get Free Report) last released its quarterly earnings data on Monday, May 5th. The company reported $1.15 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.11 by $0.04. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The business had revenue of $3.17 billion for the quarter, compared to analysts' expectations of $3.24 billion. During the same period in the previous year, the business posted $1.10 earnings per share. Henry Schein's quarterly revenue was down .1% on a year-over-year basis. Equities analysts forecast that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

Analysts Set New Price Targets

Several research firms recently weighed in on HSIC. Wall Street Zen lowered Henry Schein from a "buy" rating to a "hold" rating in a report on Thursday, April 17th. Barrington Research reduced their target price on Henry Schein from $90.00 to $86.00 and set an "outperform" rating for the company in a report on Tuesday, May 6th. UBS Group reduced their target price on Henry Schein from $83.00 to $80.00 and set a "neutral" rating for the company in a report on Wednesday, February 26th. Piper Sandler reduced their target price on Henry Schein from $83.00 to $77.00 and set an "overweight" rating for the company in a report on Wednesday, April 30th. Finally, Wells Fargo & Company dropped their price target on Henry Schein from $80.00 to $75.00 and set an "equal weight" rating on the stock in a research report on Tuesday, May 6th. Six analysts have rated the stock with a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $79.30.

Insider Buying and Selling at Henry Schein

In other Henry Schein news, CEO Bradford C. Connett sold 4,036 shares of the company's stock in a transaction on Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total value of $287,161.40. Following the sale, the chief executive officer now directly owns 62,688 shares in the company, valued at $4,460,251.20. This represents a 6.05% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Philip A. Laskawy sold 2,604 shares of the stock in a transaction on Wednesday, March 19th. The stock was sold at an average price of $71.04, for a total value of $184,988.16. Following the sale, the director now owns 24,805 shares in the company, valued at $1,762,147.20. The trade was a 9.50% decrease in their position. The disclosure for this sale can be found here. Company insiders own 1.14% of the company's stock.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.